Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

768 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation.
Christie D, Denham J, Steigler A, Lamb D, Turner S, Mameghan H, Joseph D, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Spry NA, Tai KH, Wynne C, Duchesne G, Kovacev O, Francis L, Kramar A, D'Este C, Bill D. Christie D, et al. Among authors: d este c. Radiother Oncol. 2005 Nov;77(2):117-25. doi: 10.1016/j.radonc.2005.10.005. Epub 2005 Nov 4. Radiother Oncol. 2005. PMID: 16271786 Clinical Trial.
Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer.
Denham JW, Steigler A, Tai KH, Joseph D, Matthews J, Atkinson C, Spry NA, Turner S, North J, Christie D, Wynne C, Lamb DS. Denham JW, et al. Among authors: christie d. Radiother Oncol. 2013 May;107(2):123-8. doi: 10.1016/j.radonc.2013.03.025. Epub 2013 Apr 22. Radiother Oncol. 2013. PMID: 23618502 Free article. Clinical Trial.
Paradoxical effects of the autophagy inhibitor 3-methyladenine on docetaxel-induced toxicity in PC-3 and LNCaP prostate cancer cells.
Pickard RD, Spencer BH, McFarland AJ, Bernaitis N, Davey AK, Perkins AV, Chess-Williams R, McDermott CM, Forbes A, Christie D, Anoopkumar-Dukie S. Pickard RD, et al. Among authors: christie d. Naunyn Schmiedebergs Arch Pharmacol. 2015 Jul;388(7):793-9. doi: 10.1007/s00210-015-1104-7. Epub 2015 Feb 24. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 25708950
Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group.
Lieng H, Hayden AJ, Christie DRH, Davis BJ, Eade TN, Emmett L, Holt T, Hruby G, Pryor D, Shakespeare TP, Sidhom M, Skala M, Wiltshire K, Yaxley J, Kneebone A. Lieng H, et al. Among authors: christie drh. Radiother Oncol. 2018 Nov;129(2):377-386. doi: 10.1016/j.radonc.2018.06.027. Epub 2018 Jul 20. Radiother Oncol. 2018. PMID: 30037499
Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group.
Lieng H, Kneebone A, Hayden AJ, Christie DRH, Davis BJ, Eade TN, Emmett L, Holt T, Hruby G, Pryor D, Sidhom M, Skala M, Yaxley J, Shakespeare TP. Lieng H, et al. Among authors: christie drh. Radiother Oncol. 2019 Nov;140:68-75. doi: 10.1016/j.radonc.2019.05.016. Epub 2019 Jun 6. Radiother Oncol. 2019. PMID: 31177044
The COX-2 inhibitor NS398 selectively sensitizes hypoxic HeLa cells to ionising radiation by mechanisms both dependent and independent of COX-2.
Anoopkumar-Dukie S, Conere T, Houston A, King L, Christie D, McDermott C, Allshire A. Anoopkumar-Dukie S, et al. Among authors: christie d. Prostaglandins Other Lipid Mediat. 2020 Jun;148:106422. doi: 10.1016/j.prostaglandins.2020.106422. Epub 2020 Jan 28. Prostaglandins Other Lipid Mediat. 2020. PMID: 32004752
768 results